There were 2,463 press releases posted in the last 24 hours and 441,524 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image